Similar to FABP1, the two-stage expression pattern of CDX2 and SOX9 during the initiation and development of GC was also reported previously (Uozaki et al., 2011; Sun et al., 2012), suggesting that these molecules might play different roles in different stages of gastric disease progression. The gene discussed is SOX9; the disease is stomach disorder.